Urology · Memphis, TN
NPI
1821103151
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6029 Walnut Grove Rd, Suite 300
Memphis, TN, 38120
Phone (901) 767-8158
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
53,571 services
Medicare patients, 2024
1,175
Average age 74
Drug cost, 2024
$8.2M
6,567 prescriptions
Company payments, 2025
$4,863
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walter Rayford was code J1071 (injection, testosterone cypionate, 1 mg), 35,282 times for 40 patients. In total Walter Rayford billed 53,571 services in 138 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 35,282 | 40 | $0.02 | $595 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,152 | 154 | $0.10 | $208 |
| 81003 Clinical Chemistry | Office | 1,873 | 937 | $2.12 | $3,977 |
| 82570 Clinical Chemistry | Office | 1,863 | 935 | $4.90 | $9,127 |
| 36415 Venipuncture Blood Collection | Office | 1,586 | 789 | $8.39 | $13K |
| 99213 Office E&M - Established | Office | 1,419 | 833 | $60.42 | $86K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,261 | 264 | $47.70 | $60K |
| 84153 Clinical Chemistry | Office | 1,147 | 613 | $17.41 | $20K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,062 | 22 | $44.42 | $47K |
| 84403 Clinical Chemistry | Office | 950 | 488 | $24.51 | $23K |
| 99214 Office E&M - Established | Office | 719 | 533 | $89.28 | $64K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 687 | 183 | $36.76 | $25K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 369 | 46 | $140.31 | $52K |
| 84154 Clinical Chemistry | Office | 267 | 176 | $17.41 | $4,649 |
| 86316 Immunoassay | Office | 234 | 165 | $19.78 | $4,628 |
By year: 2022 $591K for 69,843 services; 2023 $618K for 47,044 services; 2024 $1.7M for 53,571 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,873 | 937 | $2.12 | $3,977 |
| 82570 Clinical Chemistry | 1,863 | 935 | $4.90 | $9,127 |
| 36415 Venipuncture Blood Collection | 1,586 | 789 | $8.39 | $13K |
| 84153 Clinical Chemistry | 1,147 | 613 | $17.41 | $20K |
| 84403 Clinical Chemistry | 950 | 488 | $24.51 | $23K |
| 84154 Clinical Chemistry | 267 | 176 | $17.41 | $4,649 |
| 86316 Immunoassay | 234 | 165 | $19.78 | $4,628 |
| 82565 Clinical Chemistry | 193 | 177 | $4.88 | $942 |
| 88112 Surgical Pathology Examination | 187 | 154 | $19.90 | $3,721 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 35 | 35 | $17.84 | $624 |
Medicare prescription drug claims, 2024
In 2024, the drug Walter Rayford prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,457 prescriptions and refills. In total Walter Rayford wrote 6,567 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,457 | 3,612 | 518 | $24K |
| Ciprofloxacin Hcl Generic | 604 | 605 | 373 | $2,606 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 543 | 543 | 333 | $1,294 |
| Finasteride Generic | 527 | 1,384 | 174 | $6,548 |
| Xtandi Enzalutamide | 392 | 392 | 72 | $5.4M |
| Oxybutynin Chloride Er Oxybutynin Chloride | 334 | 727 | 125 | $12K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 330 | 330 | 170 | $3,903 |
| Gemtesa Vibegron | 279 | 454 | 75 | $213K |
| Myrbetriq Mirabegron | 192 | 338 | 70 | $151K |
| Orgovyx Relugolix | 176 | 179 | 31 | $456K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 170 | 170 | 128 | $807 |
| Levofloxacin Generic | 113 | 113 | 83 | $355 |
| Cefuroxime Cefuroxime Axetil | 106 | 106 | 78 | $1,054 |
| Solifenacin Succinate Generic | 98 | 208 | 32 | $5,792 |
| Nubeqa Darolutamide | 85 | 85 | 11 | $995K |
Brand drugs: - claims; generic drugs: 5,187 claims; opioid claims: 195.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walter Rayford $4,863 ($4,863 in general payments such as food, travel and fees) from 35 companies. The largest payer was Intuitive Surgical, Inc. with $1,448.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 11 | $1,448 |
| Teleflex LLC TFX | 4 | $400 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $342 |
| Coloplast Corp | 25 | $326 |
| Merck Sharp & Dohme LLC MRK | 6 | $213 |
| Janssen Biotech, Inc. JNJ | 7 | $172 |
| Procept Biorobotics Corporation PRCT | 1 | $170 |
| Endo USA, Inc. | 11 | $152 |
| Dendreon Pharmaceuticals LLC | 6 | $145 |
| Biotissue Holdings Inc. | 3 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.